# Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

> **NCT04601233** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tulane University** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Sclerosis
- Erectile Dysfunction
- Testosterone Deficiency

## Interventions

- **DRUG:** XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector

## Key facts

- **NCT ID:** NCT04601233
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04601233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04601233, "Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04601233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*